Drug Approval Package

 Neurontin (Gabapentin) Oral Solution, Capsules & Tablets
Company:  Parke-Davis
Application No.:  021216/020235S015/020882S002/021129S005
Approval Date: 10/12/2000

• Approval Letter(s) (PDF)

• Printed Labeling (PDF)

• Medical Review(s)
  Part 1 (PDF)  
  Part 2 (PDF)

• Pharmacology Review(s) (PDF)

• Statistical Review(s) (PDF)

• Clinical Pharmacology Biopharmaceutics Review(s) (PDF)

• Administrative Document(s) & Correspondence (PDF)  

Date created: May 062004

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.